Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Cancer, Hematological”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Looking for participantsNCT04771572
What this trial is testing

Study of Oral Administration of LP-118 in Patients With Relapsed or Refractory CLL, SLL, MDS, MDS/MPN, AML, CMML-2, MPN-BP, ALL, MF, NHL, RT, MM or T-PLL.

Who this might be right for
Non Hodgkin LymphomaRichter TransformationMultiple Myeloma+10 more
Newave Pharmaceutical Inc 100
Testing effectiveness (Phase 2)Study completedNCT01349101
What this trial is testing

A Research Study of Bone Marrow Transplantation From Unrelated or Partially Matched Related Donors

Who this might be right for
Hematological Malignancies
Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University 78
Not applicableStudy completedNCT04039100
What this trial is testing

Family Caregiver Ambassador Support for Family Caregivers of Patients With Hematological Disease

Who this might be right for
Multiple MyelomaLymphomaBone Marrow Transplantation+3 more
Rigshospitalet, Denmark 43
Not applicableStudy completedNCT00587912
What this trial is testing

AIDS and Cancer Specimen Bank (ACSB)

Who this might be right for
Kaposi's Sarcoma AIDS RelatedKaposi's Sarcoma ClassicalNon-Hodgkin's Lymphoma+3 more
Memorial Sloan Kettering Cancer Center 65
Testing effectiveness (Phase 2)Study completedNCT02215070
What this trial is testing

Pasireotide in Prevention of GI Toxicity

Who this might be right for
Hematological Malignancies
Anthony Sung, MD 37
Early research (Phase 1)Study completedNCT03241550
What this trial is testing

Intravenous and Oral Isavuconazonium Sulfate in Pediatric Patients

Who this might be right for
Hematological Malignancy
Astellas Pharma Global Development, Inc. 49
Not applicableStudy completedNCT04454723
What this trial is testing

Impact of Palliative Transfusions on Quality of Life in Patients With Blood Cancers on Hospice

Who this might be right for
Hematologic Malignancy
University of Oklahoma 20
Testing effectiveness (Phase 2)Study completedNCT01413568
What this trial is testing

Safety and Efficacy of POL6326 for Mobilization/Transplant of Sibling Donor in Patients With Hematologic Malignancies

Who this might be right for
Acute Myeloid Leukemia in RemissionAdult Acute Lymphoblastic Leukemia in RemissionChronic Myelogenous Leukemia (CML)+5 more
Polyphor Ltd. 38
Testing effectiveness (Phase 2)Study completedNCT00305682
What this trial is testing

Non-Myeloablative Conditioning for Unrelated Donor Umbilical Cord Blood Transplant

Who this might be right for
Myeloproliferative DisordersLeukemiaLymphoma+1 more
Masonic Cancer Center, University of Minnesota 295
Not applicableUnknownNCT02791217
What this trial is testing

Identification of Hematological Malignancies and Therapy Predication Using microRNAs as a Diagnostic Tool

Who this might be right for
Lymphoma, B-CellFollicular LymphomaHodgkin Lymphoma+1 more
Assuta Medical Center 100
Testing effectiveness (Phase 2)UnknownNCT04626908
What this trial is testing

Clinical Study of Targeting CD19 and CD22 Chimeric Antigen Receptor T Lymphocytes in the Treatment of Recurrent or Refractory B Cell Non-Hodgkin Lymphoma

Who this might be right for
Relapsed and RefractoryLymphoid Hematological Malignancies
He Huang 18
Testing effectiveness (Phase 2)Study completedNCT03128359
What this trial is testing

High Dose Cyclophosphamide, Tacrolimus, and Mycophenolate Mofetil in Preventing Graft Versus Host Disease in Patients With Hematological Malignancies Undergoing Myeloablative or Reduced Intensity Donor Stem Cell Transplant

Who this might be right for
Acute LeukemiaChronic Lymphocytic Leukemia/Small Lymphocytic LymphomaChronic Myelogenous Leukemia, BCR-ABL1 Positive+12 more
City of Hope Medical Center 38
Early research (Phase 1)Looking for participantsNCT05892718
What this trial is testing

A Safety and Efficacy Study of HCB101, Fc-fusion Protein Targeting SIRPα-CD47 Pathway, in Solid or Hematological Tumors

Who this might be right for
Advanced Solid TumorRefractory Non-Hodgkin Lymphoma
FBD Biologics Limited 80
Testing effectiveness (Phase 2)WithdrawnNCT00149032
What this trial is testing

Treatment of Patients With Donor Lymphocytes Sensitized by Antigens Expressed by the Host

Who this might be right for
Hematological MalignancyNeoplasm Metastasis
Hadassah Medical Organization 50
Testing effectiveness (Phase 2)Looking for participantsNCT07708987
What this trial is testing

Study of Standardized Withaferin-A for the Treatment of Steroid Refractory Acute Graft Versus Host Disease.

Who this might be right for
Hematological MalignancyGVHD - Graft-Versus-Host DiseaseSteriod Refractory
Tata Memorial Centre 34
Early research (Phase 1)Study completedNCT03106428
What this trial is testing

A Multiple Ascending Dose Study of MEDI7247 in Patients With Selected Relapsed/Refractory Hematological Malignancies

Who this might be right for
Acute Myeloid LeukemiaMultiple MyelomaDiffuse Large B-cell Lymphoma
MedImmune LLC 67
Not applicableLooking for participantsNCT06409767
What this trial is testing

Impact of an Early Warning System on the Prognosis of Patients With Hematological Malignancies Receiving Intensive Chemotherapy With or Without Hematopoietic Cell Transplantation.

Who this might be right for
LeukemiaLymphomaMultiple Myeloma
University Hospital, Angers 2,224
Not applicableStudy completedNCT03221075
What this trial is testing

Clinical Implications of Azole-Resistant Aspergillosis in Hematological Malignancy

Who this might be right for
Invasive Aspergillosis
University Hospital of Cologne 203
Testing effectiveness (Phase 2)UnknownNCT06238245
What this trial is testing

Combination of ATG-based Conditioning Regimen and PTCy for GVHD Prevention in Allo-HSCT After PD-1 Blockade

Who this might be right for
Graft-versus-host DiseaseHematological Malignancies
Beijing 302 Hospital 22
Testing effectiveness (Phase 2)Study completedNCT00534430
What this trial is testing

Busulfan, Etoposide, and Total-Body Irradiation in Treating Patients Undergoing Donor Stem Cell or Bone Marrow Transplant for Advanced Hematologic Cancer

Who this might be right for
LeukemiaMyelodysplastic Syndromes
City of Hope Medical Center 30
Next Page